Serum neurofilaments as candidate biomarkers of natalizumab associated progressive multifocal leukoencephalopathy-Reference-Cited by-同舟云学术

Serum neurofilaments as candidate biomarkers of natalizumab associated progressive multifocal leukoencephalopathy

Published:2019-06-26 Issue:2 Volume:86 Page:322-324
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol

Author:

Loonstra Floor C.¹^ORCID,Verberk Inge M. W.²,Wijburg Martijn T.¹³,Wattjes Mike P.³⁴,Teunissen Charlotte E.²,Oosten Bob W.¹,Uitdehaag Bernard M. J.¹,Killestein Joep¹,Kempen Zoé L. E.¹

Affiliation:

1. Department of Neurology, Amsterdam University Medical Centers, Vrije Universiteit AmsterdamAmsterdam Neuroscience, MS Center Amsterdam Amsterdam the Netherlands

2. Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam University Medical CentersVrije Universiteit Amsterdam Amsterdam the Netherlands

3. Department of Radiology and Nuclear Medicine, Amsterdam University Medical CentersVrije Universiteit Amsterdam, Amsterdam Neuroscience, MS Center Amsterdam Amsterdam the Netherlands

4. Department of Diagnostic and Interventional NeuroradiologyHanover Medical School Hanover Germany

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.25523

Reference5 articles.

1. Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab‐treated multiple sclerosis patients

2. Neurofilaments as biomarkers in neurological disorders

3. PML diagnostic criteria

4. Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy

5. Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroaxonal damage in natalizumab-treated MS patients: The role of JCV antibody titres;Multiple Sclerosis Journal;2024-06-14

2. Surrogate endpoints for progressive multifocal leukoencephalopathy;The Lancet Neurology;2024-05

3. Serum Neurofilaments are a reliable biomarker to early detect PML in Multiple Sclerosis patients;Multiple Sclerosis and Related Disorders;2023-09

4. sNFL applicability as additional monitoring tool in natalizumab extended interval dosing regimen for RRMS patients;Multiple Sclerosis and Related Disorders;2022-11

5. The 2022 Lady Estelle Wolfson lectureship on neurofilaments;Journal of Neurochemistry;2022-09-19